Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.
The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...
Үндсэн зохиолч: | Hobbs, F |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2003
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
-н: article Editorial
Хэвлэсэн: (2020-09-01) -
Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
-н: Hobbs, R, зэрэг
Хэвлэсэн: (2005) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
-н: Alberto J Lorenzatti, зэрэг
Хэвлэсэн: (2020-02-01) -
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
-н: Mach, F, зэрэг
Хэвлэсэн: (2019) -
Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
-н: Meor Anuar Shuhaili, Meor Fairuz Rizal, зэрэг
Хэвлэсэн: (2018)